Mikihiro Yunoki
Research Subjects
Mikihiro Yunoki has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Katsuro Hagiwara
School of Veterinary Medicine, Rakuno Gakuen University, Japan
2 shared publicationsKazuyoshi Ikuta
Department of Virology, Research Institute for Microbial Diseases, Osaka University, Japan
2 shared publicationsTakeru Urayama
Research & Development Division, Benesis Corporation, Japan
2 shared publications- Yuta Kanai
Department of Virology, Research Institute for Microbial Diseases, The University of Osaka
2 shared publications A. Nishida
Infectious Pathogen Research Group, Hirakata Research Laboratory, Research & Development Division, Benesis Corporation, Hirakata, Osaka, Japan
1 shared publicationAya Nishida
Research & Development Division, Benesis Corporation, Japan
1 shared publication
Latest Publications
- Open Access
- 5 January 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 1-6
Hepatitis E virus in Norway rats (Rattus norvegicus) captured around a pig farm
Background: Hepatitis E virus (HEV) transmitted via the oral route through the consumption of contaminated water or uncooked or undercooked contaminated meat has been implicated in major outbreaks. Rats may play a critical role in HEV outbreaks, considering their negative effects on environmental hygiene and food sanitation. Although the serological evidence of HEV infection in wild rodents has been reported worldwide, the infectivity and propagation of HEV in wild rats remain unknown. To investigate if rats are a possible carrier of HEV, we studied wild Norway rats (Rattus norvegicus) that were caught near a pig farm, where HEV was prevalent among the pigs. Methods: We examined 56 Norway rats for HEV. RNA from internal organs was examined for RT-PCR and positive samples were sequenced. Positive tissue samples were incubated with A549 cell line to isolate HEV. Anti-HEV antibodies were detected by ELISA. Results: Sixteen rats were seropositive, and the HEV RNA was detected in 10 of the 56 rats. Sequencing of the partial ORF1 gene from 7 samples resulted in partially sequenced HEV, belonging to genotype 3, which was genetically identical to the HEV prevalent in the swine from the source farm. The infectious HEVs were isolated from the Norway rats by using the human A549 cell line. Conclusions: There was a relatively high prevalence (17.9%) of the HEV genome in wild Norway rats. The virus was mainly detected in the liver and spleen. The results indicate that these animals might be possible carrier of swine HEV in endemic regions. The HEV contamination risk due to rats needs to be examined in human habitats.
- 5 January 2012
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 1-6
Open AccessHepatitis E virus in Norway rats (Rattus norvegicus) captured around a pig farm
Background: Hepatitis E virus (HEV) transmitted via the oral route through the consumption of contaminated water or uncooked or undercooked contaminated meat has been implicated in major outbreaks. Rats may play a critical role in HEV outbreaks, considering their negative effects on environmental hygiene and food sanitation. Although the serological evidence of HEV infection in wild rodents has been reported worldwide, the infectivity and propagation of HEV in wild rats remain unknown. To investigate if rats are a possible carrier of HEV, we studied wild Norway rats (Rattus norvegicus) that were caught near a pig farm, where HEV was prevalent among the pigs. Methods: We examined 56 Norway rats for HEV. RNA from internal organs was examined for RT-PCR and positive samples were sequenced. Positive tissue samples were incubated with A549 cell line to isolate HEV. Anti-HEV antibodies were detected by ELISA. Results: Sixteen rats were seropositive, and the HEV RNA was detected in 10 of the 56 rats. Sequencing of the partial ORF1 gene from 7 samples resulted in partially sequenced HEV, belonging to genotype 3, which was genetically identical to the HEV prevalent in the swine from the source farm. The infectious HEVs were isolated from the Norway rats by using the human A549 cell line. Conclusions: There was a relatively high prevalence (17.9%) of the HEV genome in wild Norway rats. The virus was mainly detected in the liver and spleen. The results indicate that these animals might be possible carrier of swine HEV in endemic regions. The HEV contamination risk due to rats needs to be examined in human habitats.
- 31 March 2010
- Published by Elsevier in Biologicals
- Vol. 38 (2) , 311-313
Infectious prion protein in the filtrate even after 15nm filtration
- 31 March 2010
- Published by Elsevier in Biologicals
- Vol. 38 (2) , 311-313
Infectious prion protein in the filtrate even after 15nm filtration
- Open Access
- 1 March 2010
- Published by Wiley in British Journal of Haematology
- Vol. 148 (6) , 953-955
Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1
- 1 March 2010
- Published by Wiley in British Journal of Haematology
- Vol. 148 (6) , 953-955
Open AccessSignificant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1
- 9 July 2008
- Published by Wiley in Vox Sanguinis
- Vol. 95 (2) , 94-100
Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters
Background and Objective To investigate the physico‐chemical properties of hepatitis E virus (HEV) with regard to inactivation/removal, we have studied four isolates with respect to sensitivity to heat during liquid/dry‐heating as well as removal by nanofiltration.Materials and Methods Hepatitis E virus in an albumin solution or phosphate‐buffered saline (PBS) was liquid‐heated at 60°C for a preset time. HEV in a freeze‐dried fibrinogen containing stabilizers was also dry‐heated at 60 or 80°C for a preset time. In addition, to clarify the removal of HEV, the purified virus in PBS was filtered using several types of virus‐removal filter (nanofilters) that have different pore sizes. HEV infectivity or genome equivalents before and after the treatments were assayed by a semiquantitative cell‐based infectivity assay or quantitative polymerase chain reaction assay, respectively.Results Hepatitis E virus isolates in albumin solutions were inactivated slowly at 60°C for 5 h and the resultant log reduction factor (LRF) was from 1·0 to ≥ 2·2, whereas the virus in PBS was inactivated quickly to below the detection limit and the LRF was ≥ 2·4 to ≥ 3·7. The virus in a freeze dried fibrinogen containing trisodium citrate dihydrate and l‐arginine hydrochloride as stabilizers was inactivated slowly and the LRF was 2·0 and 3·0, respectively, of the 72 h at 60°C, but inactivated to below the detection limit within 24 h at 80°C with an LRF of ≥ 4·0. The virus in PBS was also confirmed as to be approximately 35 nm in diameter by nanofiltration. These results are useful for evaluating viral safety against HEV contamination in blood products.Conclusion The sensitivity of HEV to heat was shown to vary greatly depending on the heating conditions. On the other hand, the HEV particles were completely removed using 20‐nm nanofilters. However, each inactivation/removal step should be carefully evaluated with respect to the HEV inactivation/removal capacity, which may be influenced by processing conditions such as the stabilizers used for blood products.
- 9 July 2008
- Published by Wiley in Vox Sanguinis
- Vol. 95 (2) , 94-100
Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters
Background and Objective To investigate the physico‐chemical properties of hepatitis E virus (HEV) with regard to inactivation/removal, we have studied four isolates with respect to sensitivity to heat during liquid/dry‐heating as well as removal by nanofiltration.Materials and Methods Hepatitis E virus in an albumin solution or phosphate‐buffered saline (PBS) was liquid‐heated at 60°C for a preset time. HEV in a freeze‐dried fibrinogen containing stabilizers was also dry‐heated at 60 or 80°C for a preset time. In addition, to clarify the removal of HEV, the purified virus in PBS was filtered using several types of virus‐removal filter (nanofilters) that have different pore sizes. HEV infectivity or genome equivalents before and after the treatments were assayed by a semiquantitative cell‐based infectivity assay or quantitative polymerase chain reaction assay, respectively.Results Hepatitis E virus isolates in albumin solutions were inactivated slowly at 60°C for 5 h and the resultant log reduction factor (LRF) was from 1·0 to ≥ 2·2, whereas the virus in PBS was inactivated quickly to below the detection limit and the LRF was ≥ 2·4 to ≥ 3·7. The virus in a freeze dried fibrinogen containing trisodium citrate dihydrate and l‐arginine hydrochloride as stabilizers was inactivated slowly and the LRF was 2·0 and 3·0, respectively, of the 72 h at 60°C, but inactivated to below the detection limit within 24 h at 80°C with an LRF of ≥ 4·0. The virus in PBS was also confirmed as to be approximately 35 nm in diameter by nanofiltration. These results are useful for evaluating viral safety against HEV contamination in blood products.Conclusion The sensitivity of HEV to heat was shown to vary greatly depending on the heating conditions. On the other hand, the HEV particles were completely removed using 20‐nm nanofilters. However, each inactivation/removal step should be carefully evaluated with respect to the HEV inactivation/removal capacity, which may be influenced by processing conditions such as the stabilizers used for blood products.